Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Caron

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Urology|December 17, 2024
Reply by AuthorsCylia Dahmani, Patrick Caron, David Simonyan, et al.
Annals of Hematology|May 22, 2018
Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patientsEric P Allain, Karin Venzl, Patrick Caron, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2015
Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation PotentialGuillaume Margaillan, Michèle Rouleau, Kathrin Klein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 5, 2015
Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissuesGuillaume Margaillan, Michèle Rouleau, John K Fallon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2019
A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate CancerEric Lévesque, Patrick Caron, Louis Lacombe, et al.
The Biochemical Journal|November 9, 2007
Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cellsJenny Kaeding, Emmanuel Bouchaert, Julie Bélanger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2023
Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case-Control Study in the Janus Serum BankZeni Wu, Britton Trabert, Chantal Guillemette, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 6, 2006
The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liverHugo Girard, Lyne Villeneuve, Michael H Court, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2010
Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristicsEtienne Audet-Walsh, Johanie Lépine, Jean Grégoire, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic miceMélanie Verreault, Kathy Senekeo-Effenberger, Jocelyn Trottier, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Urology|December 17, 2024
Reply by AuthorsCylia Dahmani, Patrick Caron, David Simonyan, et al.
Annals of Hematology|May 22, 2018
Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patientsEric P Allain, Karin Venzl, Patrick Caron, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2015
Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation PotentialGuillaume Margaillan, Michèle Rouleau, Kathrin Klein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 5, 2015
Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissuesGuillaume Margaillan, Michèle Rouleau, John K Fallon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2019
A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate CancerEric Lévesque, Patrick Caron, Louis Lacombe, et al.
The Biochemical Journal|November 9, 2007
Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cellsJenny Kaeding, Emmanuel Bouchaert, Julie Bélanger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2023
Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case-Control Study in the Janus Serum BankZeni Wu, Britton Trabert, Chantal Guillemette, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 6, 2006
The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liverHugo Girard, Lyne Villeneuve, Michael H Court, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2010
Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristicsEtienne Audet-Walsh, Johanie Lépine, Jean Grégoire, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic miceMélanie Verreault, Kathy Senekeo-Effenberger, Jocelyn Trottier, et al.
Pageof 10